发明名称 |
Use of NK-1 receptor antagonists in pruritus |
摘要 |
The invention relates to methods for treating pruritus with an NK-1 receptor antagonist. The invention further relates to pharmaceutical compositions comprising NK-1 receptor antagonist. |
申请公布号 |
US8906951(B1) |
申请公布日期 |
2014.12.09 |
申请号 |
US201313925509 |
申请日期 |
2013.06.24 |
申请人 |
Tigercat Pharma, Inc. |
发明人 |
Zhang Xiaoming;Schnipper Edward F.;Perlman Andrew J.;Larrick James W. |
分类号 |
A01N43/38;A61K31/405;A01N43/00;A61K31/33;A61K38/00;A61P17/00;A61K31/4035 |
主分类号 |
A01N43/38 |
代理机构 |
The Marbury Law Group PLLC |
代理人 |
The Marbury Law Group PLLC |
主权项 |
1. A method of treating chronic pruritus, said method comprising orally administering 3-[(3aR,4R,5S,7aS)-5-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-4-(4-fluorophenyl)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]cyclopent-2-en-1-one or a pharmaceutically acceptable salt or solvate thereof to a patient in need of such treatment according to a schedule, said schedule comprising:
a) first administering at least one loading dose; and b) second administering at least one therapeutically effect maintenance dose;said maintenance dose is administered chronically and comprises a dosage from about 0.1 mg to about 7.5 mg. |
地址 |
South San Francisco CA US |